Rinse-and-Spit Test Kit Company Gets $2.3M to Develop an Early Oral Cancer Screening

Rinse-and-Spit Test Kit Company Gets $2.3M to Develop an Early Oral Cancer Screening March 26, 2014 Oral cancers don’t get a lot of mainstream attention because they aren’t among the deadliest cancers by sheer numbers. They do, however, carry a surprisingly high mortality rate: between 40 and 50 percent of people diagnosed with an oral cancer die

Vigilant Closes $2.3 Million Initial Round of Financing

Vigilant Closes $2.3 Million Initial Round of Financing March 25, 2014 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced the successful completion of a $2.0 million, oversubscribed Series A financing. The company received $2.3 million in total proceeds,

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev C